Just to add a little more speculation on the conference presentation I asked Imugene the following questions and received the response from Nick Ede today. In regards to the 2024 Cholangiocarcinoma Foundation Annual Conference I would like to ask, is it normal for a biotech to be SELECTED for a conference of this type?Also is it common to be presenting an oral presentation as well as presenting a poster? Regards Hawkbar33
Hi Hawkbar33, We already had a poster accepted and we were "invited" to give a short oral presentation in addition. This is somewhat unusual so we are excited to have the opportunity to expand on the poster in an oral format to all the doctors and interested parties who will be present. Best regards,Nick Ede
While I wouldn't put too much emphasis on the response I think Imugene are looking forward to expanding on the poster presentation.
DYOR opinion only
IMU Price at posting:
10.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)